Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
By T. Patterson, G. Thompson, D. Denning, J. Fishman, S. Hadley, R. Herbrecht, D. Kontoyiannis, K. Marr, V. Morrison, M. Nguyen and 7 more. Clinical Infectious Diseases, 2016
2,332 citations recorded by the source corpus.
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.
Subfields: Epidemiology, Infectious Diseases, Oncology
View Paper: https://www.semanticscholar.org/paper/b4180b6e20abef76db30a952bfc7a2729ac2f320
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Oncology
Citations in the corpus
- Aspergillus fumigatus and Aspergillosis in 2019 (2019, methodology): “Mild, self-limited hemoptysis, seen in 50% to 90% of patients, is the typical manifestation of aspergilloma; however, occasionally hemoptysis can be massive or even fatal (25, 29).”
- Infection in Organ Transplantation (2017, methodology): “Aspergillus isolation is most common in lung recipients with colonization rates >25%, and invasive infection approaching 6% including tracheobronchitis, bronchial anastomotic infections, and invasive pulmonary (32%) and disseminated (22%) infections; these rates are greater in cystic fibrosis patien”